Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment

NCT04807257 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Fungating Wound

Interventions

COMBINATION_PRODUCT: Auger Molecular Therapy (AMT)

Sponsor

NanoRay Biotech Co., Ltd.